Greenbrook TMS Inc.
Greenbrook TMS Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Apr 15, 2022Greenbrook TMS Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Apr 1, 2024Removed from listing - SEC Form 25 filed.
SourceGBNHF stopped trading
Apr 1, 2024GBNHF is linked to Greenbrook TMS Inc. and ended with final status "acquired".
Source
Entity Graph
Greenbrook TMS Inc.issuedGBNHF
GBNHFlisted onNASDAQ
GBNHFresulted instock swap
Source-Backed Claims
- On December 5, 2024, Greenbrook TMS Inc. entered into unsecured promissory notes with Madryn Health Partners II (Cayman Master), LP and Madryn Health Partners II, LP for an aggregate principal amount of US$1,500,000.8-K
- The promissory notes issued by Greenbrook TMS Inc. mature on December 31, 2024, or earlier depending on specified conditions.8-K
- Greenbrook TMS Inc. and Neuronetics, Inc. completed a transaction on December 9, 2024, where Neuronetics acquired all issued and outstanding common shares of Greenbrook.8-K
- Each Greenbrook Share was exchanged for 0.01021 of a share of Neuronetics common stock as part of the acquisition.8-K
- Effective December 9, 2024, following the acquisition, Greenbrook TMS Inc. became an indirect, wholly owned subsidiary of Neuronetics.8-K
- On December 10, 2024, Greenbrook TMS Inc. and Neuronetics issued a joint press release announcing the completion of the acquisition.8-K
- Prior to the acquisition, on December 9, 2024, Greenbrook converted approximately US$128 million of debt into shares, resulting in 2,309,453,605 shares allocated to Madryn and its affiliates.8-K
- After the debt conversion, Madryn and its affiliates owned approximately 95.8% of the issued and outstanding Greenbrook Shares.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.